Author

Meng Zhang

Emory UniversityORCID 0000-0003-1042-6294Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Meng Zhang13 papers · QB3

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

David Alan QuigleyiD· 2 shared Emily A. EgusaiD· 2 shared Eric Jay SmalliD· 2 shared Felix Yi-Chung FengiD· 2 shared Haolong LiiD· 2 shared Hyun Jin Shin· 2 shared Jonathan ChouiD· 2 shared Lisa N. ChesneriD· 2 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

David Alan QuigleyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyNature GeneticsPeer-reviewedNov 5, 2025

Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator

Haolong Li, James E. Melnyk, Becky Xu Hua Fu…·Felix Yi-Chung Feng

This study uses CRISPR screens to identify PTGES3 as a novel modulator of AR protein levels and function in prostate cancer, showing its role in therapy resistance.

10 citationstop 2%

humangenetic perturbation / CRISPR

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 21, 2025

Identification and Characterization of PCAHIT, a Novel Long Non-Coding RNA Associated with Poor Outcomes in Prostate Cancer

Hui Li, Noah Spector Younger, Bhavna Malik…·Haolong Li

This study identifies PCAHIT, a lncRNA linked to poor outcomes in prostate cancer, showing it promotes aggressive phenotypes by affecting steroid biosynthesis and immune response.

DOI 10.1101/2025.05.21.655369

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 2, 2024

A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapy

Aishwarya Subramanian, Meng Zhang, Marina Nasrin Sharifi…·Martin Sjöström

This study identifies a gastrointestinal gene expression phenotype in metastatic castration-resistant prostate cancer that correlates with reduced response to androgen receptor inhibitors.

DOI 10.1101/2024.06.02.595931

humanbulk RNA-seq

𝕏 PostBluesky